2020
Biliary Disease: Calculous and Acalculous Cholecystitis
Davis K, Ruangvoravat L. Biliary Disease: Calculous and Acalculous Cholecystitis. DeckerMed Critical Care Of The Surgical Patient 2020 DOI: 10.2310/7ccsp.8325.ChaptersBiliary diseaseAcalculous cholecystitisElective cholecystectomyClinical deteriorationHemodynamic compromiseSecondary insultsSymptomatic cholelithiasisIll patientsSignificant morbidityExcellent outcomesPrimary etiologyCholecystitisCholelithiasisPatientsGallbladderDiseaseVast majorityCholangitisCholecystectomyMorbidityIntensivistsInflammationEtiologyInfectionMortalityBiliary Disease: Calculous and Acalculous Cholecystitis
Davis K, Ruangvoravat L. Biliary Disease: Calculous and Acalculous Cholecystitis. DeckerMed Gastroenterology Hepatology And Endoscopy 2020 DOI: 10.2310/gastro.8325.ChaptersBiliary diseaseAcalculous cholecystitisElective cholecystectomyClinical deteriorationHemodynamic compromiseSecondary insultsSymptomatic cholelithiasisIll patientsSignificant morbidityExcellent outcomesPrimary etiologyCholecystitisCholelithiasisPatientsGallbladderDiseaseVast majorityCholangitisCholecystectomyMorbidityIntensivistsInflammationEtiologyInfectionMortality
2019
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
Scrimenti A, Seabury RW, Miller CD, Ruangvoravat L, Darko W, Probst LA, Cwikla GM. Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit. Pharmacy Practice 2019, 17: 1541-1541. PMID: 31897248, PMCID: PMC6935549, DOI: 10.18549/pharmpract.2019.4.1541.Peer-Reviewed Original ResearchSurgical intensive care unitPharmacist recommendationsTrauma patientsAnti-factor XaIntensive care unitDose adjustmentMedical providersEnoxaparin doseProphylactic enoxaparinTrough concentrationsCare unitEnoxaparin dosesVTE prophylaxisChart reviewAdult patientsPharmacist participationPatientsEnoxaparinFinal analysisPharmacistsSteady-state concentrationsDoseIRB reviewProvidersLimited information